Posted inGenetics
Space Station Stem Cells Successfully Produce Healthy Mice
Decades of space exploration have resulted in the discovery of known stressors to animals (including humans) during spaceflight: radiation, microgravity,…
Posted inGenetics
Industry Partnerships with Iowa State University to Support New Scale-Up Facility
A new bioindustrial manufacturing scale-up facility has been designed to help advance innovative biobased solutions and products from the lab to…
Posted inGenetics
COMET’s Rocket Speed: AI-Designed Nanoparticles Accelerate mRNA Therapies
Using artificial intelligence (AI), researchers headed by a team at Massachusetts Institute of Technology (MIT) have come up with a…
Posted inGenetics
Stem Cell Differentiation Method Induces Meiosis to Address Infertility
There is a high unmet need for accessible, affordable, and high-quality fertility care, as approximately 1 in 6 people are…
Posted inGenetics
StockWatch: After FDA Approval, Analysts Predict Blockbuster Sales for Insmed Drug
Insmed (NASDAQ: INSM) is breathing easier since the FDA has approved the company’s Brinsupri™ (brensocatib 10 mg and 25 mg…
Posted inGenetics
Made Scientific Opens Its New GMP Manufacturing Facility and HQ in Princeton, NJ
CDMO Made Scientific held the grand opening of its new 60,000ft2 cell therapy GMP manufacturing facility and headquarters in Princeton,…
Posted inGenetics
AI-Designed Molecules Show Potent Activity Against Resistant Bacteria
Using generative artificial intelligence (generative AI), scientists from Massachusetts Institute of Technology (MIT) and their collaborators elsewhere designed novel antibiotics…
Posted inGenetics
Pancreatic Precancer Cells in Mice Reveal Autophagy Defects, Protein Clumps
In a twist that blurs the lines between two devastating diseases, scientists have spotted dementia-like behavior in the pancreas. In…
Posted inGenetics
Metastatic Cancers Eliminated by CD40 Agnostic Antibody
Over the past 20 years, a class of anticancer drugs called CD40 agonist antibodies has shown great promise but also…
Posted inGenetics
Schrödinger Halts Cancer Drug Program after Two Patients Die in Phase I Trial
Schrödinger has halted development of its cancer-fighting candidate SGR-2921 after two patients treated with the cell division cycle 7 (CDC7) inhibitor died…